Color Diagnostics, LLC

Color Diagnostics is an oncology-focused clinical care platform that delivers comprehensive cancer management services across prevention, early detection, diagnosis, active treatment, and survivorship. The company operates a licensed medical group across all 50 states staffed by board-certified oncologists who provide direct clinical care rather than navigation-only services. Color's Virtual Cancer Clinic model addresses fragmented traditional cancer care by offering 24/7 access to oncologist-led teams, at-home cancer screening and testing, peer-to-peer collaboration with treating providers, and active treatment care management with symptom monitoring. The platform targets employers, health plans, consultants, unions, and public sector organizations seeking to improve cancer outcomes while controlling costs. Key clinical capabilities include early risk identification, higher screening completion rates, fast follow-up on abnormal results, and long-term survivorship management to support return to work. Color reports clinical outcomes including 53% faster diagnosis, 62% increase in screening adherence, closure of >60% of costly care gaps, $18,235 average savings per patient, and 2.7:1 ROI in Year 1. The company serves major employers and organizations across multiple industries and demonstrates commitment to accessible, evidence-based oncology care delivery.